Completing data — refresh the page later to see the latest
577784-91-9Cc1c(-c2cc(NS(=O)(=O)c3ccccc3Cl)n(C)n2)sc2ccc(Cl)cc12BVBDTTLISMIOJY-UHFFFAOYSA-NML-60218 is an organic molecular entity. It has a role as an EC 2.7.7.6 (RNA polymerase) inhibitor.
Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
DescriptionML60218 (CAS 577784-91-9) is a broad spectrum inhibitor of RNA polymerase III fromS. Cerevisiaeas well as from human cells, IC50=32mM and 27mM respectively.1 Combined treatment with ML-60218 and an HDAC inhibitor caused augmented suppression of colony formation, induction of cell cycle arrest and apoptotic cell death in human pancreatic adenocarcinoma cells.2
UsesML-60218 is a broad-spectrum RNA pol III inhibitor, with IC50s of 32 and 27 μM for Saccharomyces cerevisiae and human. ML-60218 disrupts already assembled viroplasms and to hamper the formation of new ones without the need for de novo transcription of cellular RNAs[1][2].
General DescriptionA cell-permeable indazolo-sulfonamide compound that displays broad-spectrum inhibitory activity against RNA Polymerase III (IC50 = 27 and 32 μM for human and S. cerevisiae RNA Pol III, respectively). Inhibits cell growth in yeast by preventing RNA Pol III-mediated tRNA transcription. Also available as a 25 mM solution in DMSO (Cat. No. 557404).
577784-91-9DTXSID70384980CHEBI:232880